

S116
Poster presentations / European Geriatric Medicine 6S1 (2015) S32
–
S156
urinary tract. Elderly patients does not present with classical signs
and symptoms. If initial treatment is not working we have to look
elsewhere. If patient is not suitable for surgical intervention we
should look into alternative options.
P-317
Are there any risk factors for VRE-colonization in geriatric
patients: A case–control study
E. Pressel
1
, M. Lillevang-Johannsen
2
, M. Gamwell Dawids
2
,
E. Jimenez Solem
2
, J. Dahl Knudsen
3
1
Bispebjerg Hospital, København NV, Denmark;
2
Bispebjerg Hospital,
Copenhagen, Denmark;
3
Hvidovre Hospital, Hvidovre, Denmark
Objectives:
Colonization with vancomycine resistant Enterococcus
faecium (VRE) has been an emerging and cost-intensive problem
during the past years. Transmission pathway is faeco-orally,
exposure time and close contact to colonized patients are thought
to be important risk factors.
The aim of this study was to show possible clinical risk factors for
VRE-colonization in geriatric patients and to explore antibiotic use
and coinfection rates with
Clostridium difficile
(CD).
Methods:
In a retrospective case-control study we included all
patients admitted to the geriatric department between May
and August 2013 (n = 122), defined as cases (n = 38) or controls
(n = 84) depending on their rectal VRE colonization status during
hospitalization.
Clinical data, functional status (ADL), readmission and death rates,
data on antibiotic use 6 months prior to study period and co-
infection rate with CD 6 months before and after study period,
were collected.
Results:
Readmission rates (p
<
0.01) and length of hospital stay
were higher in cases (p = 0.03), no significant differences in
mortality rates were observed.
We found more co-infections with CD in the case group (p
<
0.01)
and a higher use of amoxicilline/clavulanate and ciprofloxacin
(p
<
0.05). No significant difference in the use of other antimicrobial
agents was observed.
No differences in age, sex, functional status and Charlsons
Comorbidity Index were found.
Conclusion:
VRE-colonized geriatric patients are characterized by
high readmission rates, long hospital stay and high coinfection rates
with CD. Clinical factors seem to play a minor role suggesting that
minimizing exposure is the most efficient strategy to avoid VRE
colonization also in these patients.
P-318
The impact of childhood 13-valent pneumococcal conjugate
vaccination on overall invasive pneumococcal disease,
including the oldest old
N. Schalck
1
, L. Henckaerts
2
, J. Verhaegen
2
, W. Peetermans
2
,
J. Flamaing
3
1
UZ Leuven, Leuven, Belgium;
2
Uz Leuven, Leuven, Belgium;
3
Department of Geriatric Medicine University Hospitals Leuven and
KU Leuven, Leuven, Belgium
Objectives:
The aim of this study was to compare serotype
distribution in invasive pneumococcal disease (IPD) in the Belgian
population before and after the introduction of the 13-valent
conjugate vaccine (PCV13) in the national childhood vaccination
schedule.
Methods:
Serotyping was performed on 9787 pleural fluid and
bacteraemic isolates (IPD-isolates) sent to the National Reference
Laboratory between 2008 and 2014. We compared the distribution
of serotypes (ST) /serogroups (SG) between the periods before
(2008–2010) and after (2012–2014) the introduction of PCV13
in children and adults of different age groups, including older
individuals (65–84 and
>
85 years).
Results:
The introduction of PCV13 in the childhood immunisation
program resulted in a reduction of 16% of all IPD-isolates. The
prevalence of PCV13-SG decreased in all age groups. A decrease
from 79% to 59% (p
<
0.005) was seen in children
<
18 years and
from 67% to 57% (p
<
0.005) in persons aged 18–64. This effect was
also observed in older persons, with a decline from 63% to 54%
(p
<
0.005) and 61% to 51% (p
<
0.005) in the age groups 65–84
and
>
85 years, respectively. Furthermore, we observed a significant
reduction in coverage rate for the 23-valent polysaccharide vaccine
after introduction of PCV13 in all ages, except for those
>
85 years,
where the coverage rate remains stable.
Conclusions:
After introduction of PCV13, a reduction of PCV13-
serotypes occurred in IPD in children, but also in other age groups,
including those aged 65–84 and
>
85 years. This indirect effect
(herd-protection) should be incorporated in the pneumococcal
vaccine strategies for (older) adults.
P-319
Risk management for patients with
Clostridium difficile
in
geriatric departments
R.-J. Schulz
1
, S. Langenfeld
1
, J. Wendel
1
1
Department of Geriatric Medicine, St. Marien-Hospital, Cologne,
Germany
Objectives:
Risk management of multimorbid patients has to take
in consideration in terms of infection diseases like
Clostridium
difficile
. The geriatric departments take over patients from
other clinic departments to continue started therapies, especially
antibiotic regiments.
Methods:
In a retrospective analyses patients were documented for
allocation from other clinic departments or from acute ambulatory
setting. This was performed as a monocentric clinical trial.
Results:
2,826 patients were screened for
Clostridium difficile
associated diarrhoea transferred from 32 different clinical
departments in 2014. 20% were allocated from an ambulatory
setting. In 167 cases the clinical diagnose were documented
and resulted in an extended treatment duration and complicated
follow up. Antibiotic history was documented and indicated a high
percentage of quinolone therapy.
Conclusions:
To avoid complicated follow up treatments and costly
therapy strategies with an higher mortality risk, it will be necessary
to document antibiotic history of geriatric patients and to perform
a risk stratification supported by antibiotic stewardship.
P-320
Course of Streptococcus pneumoniae meningitis in young
and aged mice
S. Sch ¨utze
1
, A. Manig
2
, S. Ribes
2
, S. Bunkowski
2
, R. Nau
3
1
Department of Geriatics, Agaplesion Diakonie Kliniken, Frankfurt am
Main, Germany;
2
Institute of Neuropathology, University of G¨ottingen,
G¨ottingen, Germany;
3
Department of Geriatrics, Evangelisches
Krankenhaus G¨ottingen-Weende, G¨ottingen, Germany
Objectives:
In order to elucidate the causes for the increased
incidence and mortality of aged patients with bacterial central
nervous system (CNS) infections, we compared the course of
Streptococcus pneumoniae meningitis in aged and young mice.
Methods:
Aged (21.2+3.1 months, n = 40) and young (3.2+0.9
months, n = 42) C57BL/6N and B6/SJL mice were infected
by intracerebral injection of 50–70 CFU S. pneumonia SP3
and monitored for 15 days (clinical score, motor functions,
weight). Bacterial concentrations in cerebellum and spleen were
determined by quantitative plating [median (25./75. percentile)
CFU/ml]. Leukocytes were quantified in brain sections stained
by chloracetate-esterase [meningeal inflammation score: median
(25./75. percentile)].
Results:
After intracerebral infection with S. pneumonia, aged
and young mice did not differ concerning mortality (35%